The shares of semiconductor-based power electronics provider Monolithic Power Systems (MPWR) have plunged 20.6% in price over the past six months. In addition, they are trading below their 50-day and…
Author archives: Pragya Pandey
Should You Buy the Dip in F5 Networks?
F5 Inc. (FFIV) has made consistent product and services advances and expanded its market reach over the past months. So, let’s evaluate if it would be wise to buy the…
Is Zions Bancorporation a Good Regional Bank Stock to Own in 2022?
Zions Bancorporation (ZION) has maintained stable momentum over the past year coupled with impressive profitability. However, given the company’s bleak growth prospects, is it worth adding its stock to one’s…
Is Paycom a Good Human Capital Management (HCM) Software Stock to Buy?
Leading human capital management software provider Paycom Software (PAYC) reported strong top-line growth in its last reported quarter. However, its stock has slumped nearly 38% in price over the past…
Does Allscripts Healthcare Solutions Deserve a Place in Your Portfolio?
The shares of electronic health records company Allscripts Healthcare (MDRX) have generated solid momentum over the past months on the back of earnings and revenue growth across all the company’s…
Even After the Market Correction, Continue to Avoid These 2 Meme Stocks
Concerns around macroeconomic factors have exacerbated stock market volatility, prompting investors to abandon holdings in speculative stocks. Furthermore, the meme stock frenzy that began last year is gradually ebbing since…
Down More Than 50% in the Past 3 Months, Should You Scoop Up Shares of TaskUs?
Leading tech-enabled service provider TaskUS (TASK) has attracted negative investor attention of late based on a report published by Spruce Point Capital Management analysts that alleges misleading practices by the…
Does Signet Jewelers Deserve a Place in Your Portfolio?
The shares of diamond jewelry retailer Signet Jewelers (SIG) have soared nearly 100% in price over the past year on the back of the company’s sturdy growth strategies and sound…
2 Homebuilding Stocks to Avoid as Interest Rates Rise
Rising mortgage rates have slowed refinancing and new loan originations, putting the brakes on the housing industry’s growth. Furthermore, persistent supply chain constraints and tightening labor markets continue to impair…
Is ResMed a Buy Under $250?
Currently trading at less than $250, ResMed Inc. (RMD) exhibited solid fundamental performance in its last reported quarter based on its strong sales growth across its product portfolio. So, given…